| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $13.2B | $11.7B | $9.8B | $9.0B | $7.9B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | $1.1B | $1.1B | $1.0B | $0.9B | $0.7B |
| Operating Income | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B |
| Net Income | $0.0B | $0.1B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $0.28 | $1.12 | $1.93 | $1.68 | $1.33 |
| EPS (Diluted) | $0.28 | $1.12 | $1.92 | $1.67 | $1.32 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $12.3B | $11.3B | $9.5B | $9.2B | $7.3B |
| Current Assets | $3.3B | $2.6B | $2.6B | $2.4B | $2.1B |
| Cash & Equivalents | $0.9B | $0.4B | $0.5B | $0.5B | $0.3B |
| Total Liabilities | — | — | — | — | — |
| Current Liabilities | $3.9B | $3.2B | $2.6B | $2.5B | $2.3B |
| Stockholders' Equity | $3.0B | $3.0B | $2.9B | $2.6B | $2.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.5B | $0.6B | $0.5B | $0.5B |
| Investing Cash Flow | $-0.2B | $-1.2B | $-0.4B | $-1.1B | $-0.2B |
| Capital Expenditures | $0.3B | $0.4B | $0.3B | $0.3B | $0.3B |
| Financing Cash Flow | $0.1B | $0.6B | $-0.2B | $0.8B | $-0.2B |